Alpha-ketoglutarate + ipriflavone
Alpha-ketoglutarate + ipriflavone has been studied in 1 paper since 2016: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jan 1, 2016: “The Protective and Therapeutic Effect of Exclusive and Combined Treatment with Alpha-ketoglutarate Sodium Salt and Ipriflavone on Bone Loss in Orchidectomized Rats”.
1 paper studies it3 findingsUpdated
See all 1 papers on alpha-ketoglutarate + ipriflavone
At a glance
The findings reach mice, none yet in people. 1 lab in 2 countries.
None of its findings points the other way.
- 1 lab in 2 countries
- Animals1
What did studies of alpha-ketoglutarate + ipriflavone find?
3Studies of alpha-ketoglutarate + ipriflavone measured 3 outcomes: Bone formation, Bone resorption and orchidectomy-induced bone loss.
Bone formation
upin rats1
1 study
Bone formation
upin rats1
Alpha-ketoglutarate + ipriflavone increases bone formation in rats during development of osteopenia after orchidectomy.
“AKG and IP not only inhibited bone resorption, but markedly stimulated the formation of bone tissue”
Animalsduring development of osteopenia after orchidectomytibiaAKG 1.0 mol/l; IP 50 mg/kg b.w.60 daysmales
The journal of nutrition, health & aging
Bone resorption
downin rats1
1 study
Bone resorption
downin rats1
Alpha-ketoglutarate + ipriflavone decreases bone resorption in rats during development of osteopenia after orchidectomy.
“AKG and IP not only inhibited bone resorption, but markedly stimulated the formation of bone tissue”
Animalsduring development of osteopenia after orchidectomytibiaAKG 1.0 mol/l; IP 50 mg/kg b.w.60 daysmales
The journal of nutrition, health & aging
Orchidectomy-induced bone loss
downin rats1
1 study
Orchidectomy-induced bone loss
downin rats1
Alpha-ketoglutarate + ipriflavone protects against orchidectomy-induced bone loss in rats (combined treatment after establishment of osteopenia).
“combined treatment with AKG and IP protected the bone tissue against orchidectomy-induced bone loss”
Animalscombined treatment after establishment of osteopeniatibiaAKG 1.0 mol/l; IP 50 mg/kg b.w.60 daysmales
The journal of nutrition, health & aging